Literature DB >> 15168327

Ultrastructural changes in bones of the senescence-accelerated mouse (SAMP6): a murine model for senile osteoporosis.

H Chen1, S Shoumura, S Emura.   

Abstract

SAMP6, a substrain of senescence-accelerated mice, was developed as an animal model for senile osteoporosis. In the present study, we investigated the bone morphology, together with serum calcium and bone mineral density (BMD) in SAMP6 and age-matched normal mice SAMR1. We did not find any significant differences between SAMR1 and SAMP6 at 1 month of age with regard to the serum compositions and bone morphology. As compared with SAMR1, BMD, the femoral weight, femoral calcium and phosphorus levels were significantly reduced in SAMP6 at 2 and 5 months of age. The number of osteoblasts in trabecular bones was also significantly reduced. Swollen mitochondria and myelin-like structures were found in osteoblasts and osteocytes of SAMP6 mice at 2 and 5 months of age. There was a greater proportion of resting surface and less forming surface in the femoral endosteal surfaces of SAMP6 mice. The amount of trabecular bone in the lumbar vertebra and the distal metaphysis of the femur was reduced. The number of the mast cells in bone marrow of the tibia significantly increased in SAMP6 mice. These findings indicate that the lower bone mass in SAMP6 was due to the reduction in osteoblast formation and suggested that mast cells in bone marrows play a role in the pathogenesis of senile osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15168327     DOI: 10.14670/HH-19.677

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  13 in total

Review 1.  The osteocyte plays multiple roles in bone remodeling and mineral homeostasis.

Authors:  Huayue Chen; Takao Senda; Kin-ya Kubo
Journal:  Med Mol Morphol       Date:  2015-03-20       Impact factor: 2.309

2.  Sex steroids during bone growth: a comparative study between mouse models for hypogonadal and senile osteoporosis.

Authors:  J Ophoff; K Venken; F Callewaert; S Boonen; R Bouillon; D Vanderschueren
Journal:  Osteoporos Int       Date:  2009-02-24       Impact factor: 4.507

Review 3.  Animal models for fracture treatment in osteoporosis.

Authors:  Marcus Egermann; J Goldhahn; E Schneider
Journal:  Osteoporos Int       Date:  2005-03-05       Impact factor: 4.507

4.  Regional variations of vertebral trabecular bone microstructure with age and gender.

Authors:  H Chen; S Shoumura; S Emura; Y Bunai
Journal:  Osteoporos Int       Date:  2008-03-11       Impact factor: 4.507

Review 5.  Morphological and molecular characterization of the senile osteoporosis in senescence-accelerated mouse prone 6 (SAMP6).

Authors:  Kagaku Azuma; Qian Zhou; Kin-Ya Kubo
Journal:  Med Mol Morphol       Date:  2018-04-04       Impact factor: 2.309

6.  MODERATE PHYSICAL ACTIVITY IMPROVES RAT BONE ULTRASTRUCTURE IN EXPERIMENTAL OSTEOPOROSIS.

Authors:  M Horge; C Crãciun; S Tripon; D Giulei; A Jompan; A Hermenean; C Roşioru
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Oct-Dec       Impact factor: 0.877

7.  Core level regulatory network of osteoblast as molecular mechanism for osteoporosis and treatment.

Authors:  Ruoshi Yuan; Shengfei Ma; Xiaomei Zhu; Jun Li; Yuhong Liang; Tao Liu; Yanxia Zhu; Bingbing Zhang; Shuang Tan; Huajie Guo; Shuguang Guan; Ping Ao; Guangqian Zhou
Journal:  Oncotarget       Date:  2016-01-26

8.  Aberrant bone density in aging mice lacking the adenosine transporter ENT1.

Authors:  David J Hinton; Meghan E McGee-Lawrence; Moonnoh R Lee; Hoi K Kwong; Jennifer J Westendorf; Doo-Sup Choi
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

Review 9.  Characterization of senescence-accelerated mouse prone 6 (SAMP6) as an animal model for brain research.

Authors:  Kimie Niimi; Eiki Takahashi
Journal:  Exp Anim       Date:  2014

10.  Increased Bone Mass in Female Mice Lacking Mast Cell Chymase.

Authors:  Thomas Lind; Ann-Marie Gustafson; Gabriela Calounova; Lijuan Hu; Annica Rasmusson; Kenneth B Jonsson; Sara Wernersson; Magnus Åbrink; Göran Andersson; Sune Larsson; Håkan Melhus; Gunnar Pejler
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.